Literature DB >> 1909397

Different clinical presentations of a lupus anticoagulant in the same family.

R M Jolidon1, H Knecht, L Humair, A de Torrente.   

Abstract

A young man who had suffered several episodes of deep-vein thrombosis of the legs since the age of 20 had a myocardial infarction at the age of 33, at which time both a prolonged partial thromboplastin time (PTT), compatible with a lupus anticoagulant (LA), and decreased fibrinolytic capacity (FC) were found. His sister presented with deep-vein thrombosis of a leg and subsequent pulmonary embolism when she was 18 years old. She had a miscarriage three years later and developed a hemolytic-uremic syndrome at the age of 35. The PT and FC were normal. Laboratory investigations of the parents revealed positive antinuclear antibodies in the mother's serum but no anomaly in the father. This study suggests a familial tendency to develop autoimmune disorders associated with LA and thromboembolic complications related to decreased FC.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909397     DOI: 10.1007/bf02115779

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  17 in total

1.  Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wassermann reaction; a study in two cases.

Authors:  A B LAURELL; I M NILSSON
Journal:  J Lab Clin Med       Date:  1957-05

2.  Lupus anticoagulant in the acquired immunodeficiency syndrome.

Authors:  E J Bloom; D I Abrams; G Rodgers
Journal:  JAMA       Date:  1986-07-25       Impact factor: 56.272

3.  Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature.

Authors:  K Lechner; I Pabinger-Fasching
Journal:  Haemostasis       Date:  1985

4.  Lupus anticoagulant and pregnancy management.

Authors:  R G Farquharson; J F Pearson; L John
Journal:  Lancet       Date:  1984-07-28       Impact factor: 79.321

5.  Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986.

Authors:  E N Harris; A E Gharavi; S P Patel; G R Hughes
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

6.  Successful pregnancy in systemic lupus erythematosus with an untreated lupus anticoagulant.

Authors:  F J Stafford-Brady; D D Gladman; M B Urowitz
Journal:  Arch Intern Med       Date:  1988-07

7.  Thromboembolism in patients with the 'lupus'-type circulating anticoagulant.

Authors:  M Elias; A Eldor
Journal:  Arch Intern Med       Date:  1984-03

8.  Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases.

Authors:  D A Gastineau; F J Kazmier; W L Nichols; E J Bowie
Journal:  Am J Hematol       Date:  1985-07       Impact factor: 10.047

9.  The relationship between lupus anticoagulants and antibodies to phospholipid.

Authors:  D A Triplett; J T Brandt; K A Musgrave; C A Orr
Journal:  JAMA       Date:  1988 Jan 22-29       Impact factor: 56.272

10.  The lupus anticoagulant. A disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA.

Authors:  C B Colaco; K B Elkon
Journal:  Arthritis Rheum       Date:  1985-01
View more
  1 in total

Review 1.  Pathophysiology of the antiphospholipid antibody syndrome.

Authors:  Rohan Willis; Silvia S Pierangeli
Journal:  Auto Immun Highlights       Date:  2011-03-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.